.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Argus Health
McKesson
Harvard Business School
Fuji
Daiichi Sankyo
Dow
Merck
Teva
Express Scripts

Generated: January 20, 2018

DrugPatentWatch Database Preview

Patent Applications for URSODIOL

« Back to Dashboard

US Patent Applications for URSODIOL

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
➤ Subscribe➤ SubscribeFATTY ACID-PHARMACEUTICAL AGENT CONJUGATES2000-12-05Patented Case2003-05-21
➤ Subscribe➤ SubscribeSystemic administration of a therapeutic preparation2000-12-06Abandoned -- Failure to Respond to an Office Action2003-06-06
➤ Subscribe➤ SubscribeMEIOSIS REGULATING COMPOUNDS2001-01-12Patented Case2002-05-31
➤ Subscribe➤ SubscribeSECRETORY LEUKOCYTE PROTEASE INHIBITOR DRY POWDER PHARMACEUTICAL COMPOSITIONS1997-10-03Abandoned -- Failure to Respond to an Office Action2002-03-09
➤ Subscribe➤ SubscribeIMMUNOMODULATING COMPOSITIONS FOR TREATMENT OF IMMUNE SYSTEM DISORDERS2001-01-17Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622015-08-17
➤ Subscribe➤ SubscribeDERIVATIVES OF GLP-1 ANALOGS1999-09-16Patented Case2002-09-12
➤ Subscribe➤ SubscribeUse of an angiogenesis inhibitor as a lead compound in drug development2001-03-29Abandoned -- Failure to Respond to an Office Action2002-12-30
➤ Subscribe➤ SubscribeSTRAINS OF BACTERIA AND PHARMACEUTICAL COMPOSITION CONTAINING ONE OR MORE OF SUCH STRAINS AND USE OF SAME FOR PREVENTING AND TREATING DISEASES ASSOCIATED WITH OR CAUSED BY ALTERED METABOLISM OF BILE ACIDS2001-03-02Abandoned -- After Examiner's Answer or Board of Appeals Decision2010-09-30
➤ Subscribe➤ SubscribeSystemic administration of a therapeutic preparation2001-02-14Abandoned -- Failure to Respond to an Office Action2003-06-06
➤ Subscribe➤ SubscribeMETHOD AND APPARATUS TO EXERCISE DEVELOPMENTALLY DELAYED, PHYSICALLY AND/OR NEUROLOGICALLY IMPAIRED PERSONS2001-05-02Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622013-06-10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Cantor Fitzgerald
Healthtrust
Cerilliant
Dow
Federal Trade Commission
Merck
Chinese Patent Office
Chubb
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot